Skip to main content
. 2018 Jan 20;9(9):8706–8715. doi: 10.18632/oncotarget.24283

Figure 2. Forrest plot diagrams: Relative risk (RR) with 95% confidence interval (CI) of responses between anti-PD1/PD-L1 mAbs and standard of care (SOC).

Figure 2

(A) Complete response (CR). (B) Partial response (PR). (C) Stable disease (SD). (D) Progressive disease (PD).